Your Weight Loss Journey Begins: What Happens After Your First Shot of Wegovy

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in your brain and digestive system, signaling fullness and reducing hunger hormones within hours of your first injection. Most patients notice appetite suppression within 24 to 72 hours, though individual timing varies based on genetics, metabolism, and starting dose. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required, allowing you to begin treatment immediately while your body adapts.

What Happens in the First 24 Hours After Your Semaglutide Injection

During the first day, semaglutide begins binding to GLP-1 receptors throughout your gastrointestinal tract and central nervous system. You may experience mild nausea, particularly if you eat a full meal or consume fatty foods, since the medication slows gastric emptying—the rate at which your stomach moves food into the small intestine. Some patients report a subtle sensation of fullness or reduced food cravings by evening, while others notice minimal change until day two or three.

Injection site reactions are typically mild and localized to the area where you administered the shot. Mild redness, swelling, or tenderness that resolves within a few hours is normal and does not indicate an allergic response. If you experience severe swelling, warmth that spreads beyond the injection site, or signs of infection, contact your healthcare provider immediately.

Appetite Suppression and Hunger Changes in Week 1

The appetite-suppressing effects of semaglutide emerge as the medication accumulates in your system throughout the first week. Clinical trials show that 65–70% of patients experience noticeable hunger reduction by day five to seven, with appetite control intensifying as weeks progress. You may find that foods you previously craved—particularly high-calorie, high-fat options—no longer appeal to you, a shift driven by altered dopamine signaling in your brain's reward pathways.

Portion sizes naturally decrease because your satiety signals activate earlier and remain stronger throughout meals. Many patients report feeling satisfied after eating 40–50% of their normal pre-medication portion, which supports calorie reduction without conscious restriction or hunger-driven willpower battles. This physiological advantage is why semaglutide therapy produces sustainable weight loss rather than temporary diet-driven results.

Common Side Effects During Your First Week

Nausea is the most frequently reported side effect in week one, affecting approximately 40–50% of new users, though severity ranges from mild queasiness to temporary discomfort. Nausea typically peaks 2–4 hours after injection and resolves within 24–48 hours as your body adapts; it often improves significantly by week three as your system becomes accustomed to the medication. Eating smaller, protein-rich meals with adequate hydration and avoiding greasy or overly sweet foods minimizes nausea in these early days.

Constipation, fatigue, and mild dizziness occur in 15–30% of patients during the first one to two weeks. These effects result from slowed gastric movement, metabolic adjustment, and your body's natural response to reduced calorie intake. Increasing water intake to 80–100 ounces daily, consuming fiber-rich foods gradually, and allowing yourself adequate sleep support symptom resolution without medication adjustment.

Optimizing Your Results: Genetics, Dose Timing, and PlexusDx Personalization

Individual response to semaglutide depends partly on genetic variation in GLP-1 receptor sensitivity and related metabolic pathways. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway analysis examining 14 pathways and 49 peptides—to identify how variants in genes like FTO rs9939609 influence your appetite regulation and weight loss potential. This genetic insight, available for $298, enables precise prediction of your therapy response and optimal compound selection.

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a guarantee that your dose may increase, but your price won't—a pricing model designed to remove barriers to finding your optimal therapeutic dose. All medications source from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and consistency. HSA and FSA accounts cover treatment, and PlexusDx serves all 50 states without insurance requirements or membership fees, making personalized GLP-1 therapy accessible from day one.

When to Contact Your Provider and What Signals Progress

Contact your provider immediately if you experience severe abdominal pain, persistent vomiting lasting more than a few hours, signs of dehydration (extreme thirst, dark urine, dizziness upon standing), or any indication of allergic reaction such as difficulty breathing or facial swelling. Mild to moderate nausea, slight appetite reduction, or minor fatigue do not require urgent intervention but warrant documentation so your PlexusDx team can monitor your adaptation pattern.

Positive early signals include appetite reduction within 24–72 hours, natural portion size decrease, reduced food cravings—especially for sweets and fried foods—and stable energy despite eating fewer calories. Weight loss in week one typically ranges from 1–2 pounds due to initial fluid loss and reduced food intake; this pace often continues or accelerates in subsequent weeks as medication effects plateau and your body adapts. By week two to three, most patients report clearly noticing behavioral shifts in eating patterns and food preferences without conscious effort.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will I feel sick immediately after my first semaglutide injection?

Most patients experience mild to no symptoms in the first few hours, with nausea—if it occurs—typically emerging 2–4 hours post-injection and resolving within 24 hours. Eating a small, protein-rich meal 30–60 minutes after injection and avoiding high-fat foods minimizes discomfort. Severity varies based on individual metabolism, genetics, and starting dose.

How much weight can I expect to lose in my first week on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does PlexusDx raise my price if I need a higher dose of semaglutide?

No—PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan flat, and your price remains the same if your dose increases. This transparent pricing model means you can find your optimal therapeutic dose without fear of escalating costs, and HSA/FSA accounts cover the expense across all 50 states.

Is compounded semaglutide from PlexusDx safe and effective?

Yes; PlexusDx sources all medications exclusively from licensed 503A compounding pharmacies, which operate under strict FDA oversight and pharmaceutical standards. Compounded semaglutide has the same active pharmaceutical ingredient as brand-name products and produces equivalent clinical outcomes; it is not FDA-approved as a standalone product but meets rigorous purity and potency standards equivalent to FDA-regulated medications.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test examines variants in FTO and MC4R, and GIPR genes that influence appetite regulation and metabolic response to GLP-1 therapy. Patients with specific genetic profiles show faster or slower appetite suppression onset and varying weight loss velocity; this insight—available for $298—allows your PlexusDx provider to personalize your treatment strategy and set realistic expectations for your first week and beyond.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.